Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Tempest Therapeutics, Inc. | Corporate Controller | Common Stock | 22.2K | $47.9K | $2.16 | Jun 28, 2024 | Direct |
Tempest Therapeutics, Inc. | Corporate Controller | Employee Stock Option (right to buy) | 26.5K | Jan 3, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TPST | Tempest Therapeutics, Inc. | Jun 28, 2024 | 1 | $16.2K | 4 | Jul 2, 2024 | Corporate Controller |
TPST | Tempest Therapeutics, Inc. | Jan 3, 2024 | 1 | $0 | 4 | Jan 5, 2024 | Principal Accounting Officer |
TPST | Tempest Therapeutics, Inc. | Oct 11, 2023 | 1 | $0 | 4 | Oct 13, 2023 | Corporate Controller |
TPST | Tempest Therapeutics, Inc. | Jan 3, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Corporate Controller |
TPST | Tempest Therapeutics, Inc. | Oct 3, 2022 | 1 | $0 | 4 | Oct 4, 2022 | Corporate Controller |
TPST | Tempest Therapeutics, Inc. | Sep 30, 2022 | 0 | $0 | 3 | Oct 4, 2022 | Corporate Controller |